etifoxine

DRUG2 trials

Sponsors

Biocodex, Imperial College London

Conditions

Healthy VolunteersMultiple Sclerosis

Phase 3

Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly

CompletedNCT02147548

BiocodexHealthy Volunteers

Start: 2013-12-31End: 2015-10-31Updated: 2016-07-27

Unknown Phase

Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory Target

RecruitingNCT03850301

Imperial College LondonMultiple Sclerosis

Start: 2018-01-01End: 2025-01-31Target: 44Updated: 2024-10-15